“Safety of Tralokinumab in Pediatric Patients Aged 12-17 Years With Moderate to Severe Atopic Dermatitis: Results from the Phase 3 ECZTRA 6 Trial”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s140. Accessed April 18, 2025. https://skin.dermsquared.com/skin/article/view/2029.